✉news HealthNutrition first seen 1 d ago, last 13 h ago, peak #3
Study links pre-diagnostic plasma metabolites to triple-negative breast cancer risk
Original: Prospective analysis of pre-diagnostic untargeted plasma metabolomics and risk of triple-negative breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Researchers with the International Agency for Research on Cancer analysed pre-diagnostic untargeted plasma metabolomics data within the European Prospective Investigation into Cancer and Nutrition (EPIC) to assess whether metabolic signatures measured before diagnosis predict the risk of triple-negative breast cancer. The prospective design strengthens the findings, as metabolic markers were recorded years before any cancer appeared. The study may help identify biological pathways and early indicators for this aggressive cancer subtype.
Why now: New prospective research offers potential early markers for an aggressive breast cancer subtype.
International Agency for Research on CancerEuropean Prospective Investigation into Cancer and Nutritiontriple-negative breast cancer
Rank over time, top of the chart is #1. 15 snapshots from 1 d ago to 13 h ago.
Evidence
- Prospective analysis of pre-diagnostic untargeted plasma metabolomics and risk of triple-negative breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) · International Agency for Research on Cancer (IARC)
API: https://socialmediatrends-api.osmike.com/v1/trends/615614